Based on such findings, guideline-directed medical therapy currently recommends SGLT2 inhibitors for people with type 2 diabetes mellitus who are at risk for HF, have pre-HF, or have established HF [92]
Curr Diabetes Rev 19:3145 Gejl M, Gjedde A, Egefjord L et al (2016) In Alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial
The Takeaway few patients are being prescribed these life-saving drugs for diabetes management and reduced cardiovascular risk , possibly due to uncertainties of dosing, lack of knowledge of the CVOTs, clinical inertia, high costs, and tolerability
The highest retatrutide dose produced the biggest number in the Phase 3 TRIUMPH-1 trial: an average body-weight reduction of 28.3% at 80 weeks
Andrew Dudum, Hims & Hers Co-Founder, Chairman, and CEO Healthcare Executive Orders Galore Some pretty notable executive orders in healthcare happened in February
The state-by-state variability creates a geographic lottery effect